IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martin, K. R. G.
Right arrow Articles by Quigley, H. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martin, K. R. G.
Right arrow Articles by Quigley, H. A.
(Investigative Ophthalmology and Visual Science. 2002;43:2236-2243.)
© 2002 by The Association for Research in Vision and Ophthalmology, Inc.

Retinal Glutamate Transporter Changes in Experimental Glaucoma and after Optic Nerve Transection in The Rat

Keith R. G. Martin, Hana Levkovitch-Verbin, Danielle Valenta, Lisa Baumrind, Mary Ellen Pease and Harry A. Quigley

From the Glaucoma Research Laboratory, Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland.

PURPOSE. High levels of glutamate can be toxic to retinal ganglion cells. Effective buffering of extracellular glutamate by retinal glutamate transporters is therefore important. This study was conducted to investigate whether glutamate transporter changes occur with two models of optic nerve injury in the rat.

METHODS. Glaucoma was induced in one eye of 35 adult Wistar rats by translimbal diode laser treatment to the trabecular meshwork. Twenty-five more rats underwent unilateral optic nerve transection. Two glutamate transporters, GLAST (EAAT-1) and GLT-1 (EAAT-2), were studied by immunohistochemistry and quantitative Western blot analysis. Treated and control eyes were compared 3 days and 1, 4, and 6 weeks after injury. Optic nerve damage was assessed semiquantitatively in epoxy-embedded optic nerve cross sections.

RESULTS. Trabecular laser treatment resulted in moderate intraocular pressure (IOP) elevation in all animals. After 1 to 6 weeks of experimental glaucoma, all treated eyes had significant optic nerve damage. Glutamate transporter changes were not detected by immunohistochemistry. Western blot analysis demonstrated significantly reduced GLT-1 in glaucomatous eyes compared with control eyes at 3 days (29.3% ± 6.7%, P = 0.01), 1 week (55.5% ± 13.6%, P = 0.02), 4 weeks (27.2% ± 10.1%, P = 0.05), and 6 weeks (38.1% ± 7.9%, P = 0.01; mean reduction ± SEM, paired t-tests, n = 5 animals per group, four duplicate Western blot analyses per eye). The magnitude of the reduction in GLT-1 correlated significantly with mean IOP in the glaucomatous eye (r2 = 0.31, P = 0.01, linear regression). GLAST was significantly reduced (33.8% ± 8.1%, mean ± SEM) after 4 weeks of elevated IOP (P = 0.01, paired t-test, n = 5 animals per group). In contrast to glaucoma, optic nerve transection resulted in an increase in GLT-1 compared with the control eye (P = 0.01, paired t-test, n = 15 animals). There was no significant change in GLAST after transection.

CONCLUSIONS. GLT-1 and GLAST were significantly reduced in an experimental rat glaucoma model, a response that was not found after optic nerve transection. Reductions in GLT-1 and GLAST may increase the potential for glutamate-induced injury to RGC in glaucoma.




This article has been cited by other articles:


Home page
NeuroscientistHome page
C. Villmann and C.-M. Becker
On the Hypes and Falls in Neuroprotection: Targeting the NMDA Receptor
Neuroscientist, December 1, 2007; 13(6): 594 - 615.
[Abstract] [PDF]


Home page
IOVSHome page
G. Tezel, C. Luo, and X. Yang
Accelerated Aging in Glaucoma: Immunohistochemical Assessment of Advanced Glycation End Products in the Human Retina and Optic Nerve Head
Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1201 - 1211.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
R. K. P. Sullivan, E. WoldeMussie, L. Macnab, G. Ruiz, and D. V. Pow
Evoked Expression of the Glutamate Transporter GLT-1c in Retinal Ganglion Cells in Human Glaucoma and in a Rat Model.
Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3853 - 3859.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
L. Guo, T. E. Salt, A. Maass, V. Luong, S. E. Moss, F. W. Fitzke, and M. F. Cordeiro
Assessment of Neuroprotective Effects of Glutamate Modulation on Glaucoma-Related Retinal Ganglion Cell Apoptosis In Vivo
Invest. Ophthalmol. Vis. Sci., February 1, 2006; 47(2): 626 - 633.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
H. A. Quigley
Glaucoma: Macrocosm to Microcosm The Friedenwald Lecture
Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2663 - 2670.
[Full Text] [PDF]


Home page
IOVSHome page
O. Uckermann, S. Uhlmann, T. Pannicke, M. Francke, R. Gamsalijew, F. Makarov, E. Ulbricht, P. Wiedemann, A. Reichenbach, N. N. Osborne, et al.
Ischemia-Reperfusion Causes Exudative Detachment of the Rabbit Retina
Invest. Ophthalmol. Vis. Sci., July 1, 2005; 46(7): 2592 - 2600.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
P. Maher and A. Hanneken
The Molecular Basis of Oxidative Stress-Induced Cell Death in an Immortalized Retinal Ganglion Cell Line
Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 749 - 757.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
L. Guo, S. E. Moss, R. A. Alexander, R. R. Ali, F. W. Fitzke, and M. F. Cordeiro
Retinal Ganglion Cell Apoptosis in Glaucoma Is Related to Intraocular Pressure and IOP-Induced Effects on Extracellular Matrix
Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 175 - 182.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
S. Wamsley, B. T. Gabelt, D. B. Dahl, G. L. Case, R. W. Sherwood, C. A. May, M. R. Hernandez, and P. L. Kaufman
Vitreous Glutamate Concentration and Axon Loss in Monkeys With Experimental Glaucoma
Arch Ophthalmol, January 1, 2005; 123(1): 64 - 70.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
W. A. Hare, E. WoldeMussie, R. K. Lai, H. Ton, G. Ruiz, T. Chun, and L. Wheeler
Efficacy and Safety of Memantine Treatment for Reduction of Changes Associated with Experimental Glaucoma in Monkey, I: Functional Measures
Invest. Ophthalmol. Vis. Sci., August 1, 2004; 45(8): 2625 - 2639.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
R. H. Farkas, I. Chowers, A. S. Hackam, M. Kageyama, R. W. Nickells, D. C. Otteson, E. J. Duh, C. Wang, D. F. Valenta, T. L. Gunatilaka, et al.
Increased Expression of Iron-Regulating Genes in Monkey and Human Glaucoma
Invest. Ophthalmol. Vis. Sci., May 1, 2004; 45(5): 1410 - 1417.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
F. Ahmed, K. M. Brown, D. A. Stephan, J. C. Morrison, E. C. Johnson, and S. I. Tomarev
Microarray Analysis of Changes in mRNA Levels in the Rat Retina after Experimental Elevation of Intraocular Pressure
Invest. Ophthalmol. Vis. Sci., April 1, 2004; 45(4): 1247 - 1258.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. Maeda, A. Sawada, M. Matsubara, Y. Nakai, A. Hara, and T. Yamamoto
A Novel Neuroprotectant against Retinal Ganglion Cell Damage in a Glaucoma Model and an Optic Nerve Crush Model in the Rat
Invest. Ophthalmol. Vis. Sci., March 1, 2004; 45(3): 851 - 856.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
T. T. Lam, J. M. K. Kwong, and M. O. M. Tso
Early Glial Responses after Acute Elevated Intraocular Pressure in Rats
Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 638 - 645.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Association for Research in Vision and Ophthalmology